Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AcureOmics has developed robust metabolomics-based methods for point-of-care diagnosis of diseases such as arthritis, with promising results distinguishing healthy from diseased subjects. The company has contributed to major EU research projects targeting metabolic diseases of the liver/pancreas and rare neurodegenerative conditions like Batten disease by providing advanced metabolomic profiling capabilities. No clinical trial results are reported since they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AcureOmics.